As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs
Novo Nordisk’s multibillion-dollar honeymoon phase spearheaded by Ozempic and Wegovy is ending. Now the Danish drugmaker is ...
Wafaa Mamilli To Join Roche As Chief Digital Technology Officer
Wafaa Mamilli will join Roche as the company's new Chief Digital Technology Officer in February. This follows expansive roles ...
Seeking Alpha1mon
Novo Nordisk Vs. Eli Lilly: Obesity Makes Their Future Bright, But One Of Them Has More Potential
Relating price to CFO (cash from operations), it is clear that Novo Nordisk is much cheaper than Eli Lilly. In particular, Novo Nordisk's current value is slightly below the 10-year average ...
The Motley Fool3d
With Zepbound Not Matching Expectations, Should Investors Give Up on Eli Lilly?
Eli Lilly's sales growth is coming short of expectations, which is a problem considering its valuation. The company does have a vast lineup and a deep pipeline that go beyond diabetes and obesity.